Modeling Melanoma In Vitro and In Vivo

The behavior of melanoma cells has traditionally been studied in vitro in two-dimensional cell culture with cells adhering to plastic dishes. However, in order to mimic the three-dimensional architecture of a melanoma, as well as its interactions with the tumor microenvironment, there has been the need for more physiologically relevant models. This has been achieved by designing 3D in vitro models of melanoma, such as melanoma spheroids embedded in extracellular matrix or organotypic skin reconstructs. In vivo melanoma models have typically relied on the growth of tumor xenografts in immunocompromised mice. Several genetically engineered mouse models have now been developed which allow the generation of spontaneous melanoma. Melanoma models have also been established in other species such as zebrafish, which are more conducive to imaging and high throughput studies. We will discuss these models as well as novel techniques that are relevant to the study of the molecular mechanisms underlying melanoma progression.

[1]  A. Trumpp,et al.  Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. , 2005, Cancer research.

[2]  Kam Y. J. Zhang,et al.  Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity , 2008, Proceedings of the National Academy of Sciences.

[3]  K. Flaherty,et al.  Meeting report: The future of preclinical mouse models in melanoma treatment is now , 2013, Pigment cell & melanoma research.

[4]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[5]  S. Morrison,et al.  Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. , 2010, Cancer cell.

[6]  L. Zon,et al.  The art and design of genetic screens: zebrafish , 2001, Nature Reviews Genetics.

[7]  T. Terzian,et al.  Modelling melanoma in mice , 2011, Pigment cell & melanoma research.

[8]  Yu Shyr,et al.  Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. , 2012, The New England journal of medicine.

[9]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[10]  R. Ley Animal models of ultraviolet radiation (UVR)-induced cutaneous melanoma. , 2002, Frontiers in bioscience : a journal and virtual library.

[11]  M. Herlyn,et al.  The Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor AZD6244 (ARRY-142886) Induces Growth Arrest in Melanoma Cells and Tumor Regression When Combined with Docetaxel , 2008, Clinical Cancer Research.

[12]  L. Larue,et al.  Cutaneous melanoma in genetically modified animals. , 2007, Pigment cell research.

[13]  K. Flaherty,et al.  Inhibition of mutated, activated BRAF in metastatic melanoma. , 2010, The New England journal of medicine.

[14]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  N. Haass,et al.  Cell-cell and cell-matrix contacts in melanoma and the tumor microenvironment , 2011 .

[16]  Kam Y. J. Zhang,et al.  Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma , 2010, Nature.

[17]  A. Hauschild,et al.  Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.

[18]  R. Scolyer,et al.  Activation of the extracellular signal regulated kinase (ERK) pathway in human melanoma , 2005, Journal of Clinical Pathology.

[19]  M. Herlyn,et al.  Adhesion, migration and communication in melanocytes and melanoma. , 2005, Pigment cell research.

[20]  G. Nicolson,et al.  Organ selectivity for implantation survival and growth of B16 melanoma variant tumor lines. , 1976, Journal of the National Cancer Institute.

[21]  M. Grabherr,et al.  A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse , 2008, Nature Genetics.

[22]  S. Beissert,et al.  Development of a human three-dimensional organotypic skin-melanoma spheroid model for in vitro drug testing , 2013, Cell Death and Disease.

[23]  D. Elder,et al.  E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. , 2000, The American journal of pathology.

[24]  M. Herlyn,et al.  Fibroblasts contribute to melanoma tumor growth and drug resistance. , 2011, Molecular pharmaceutics.

[25]  M. Herlyn,et al.  PLX4032, a potent inhibitor of the B‐Raf V600E oncogene, selectively inhibits V600E‐positive melanomas , 2010, Pigment cell & melanoma research.

[26]  M. Herlyn,et al.  Melanocytes: From Morphology to Application , 2009, Skin Pharmacology and Physiology.

[27]  Wolfgang Weninger,et al.  A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells. , 2013, Cancer research.

[28]  Kevin W. Eliceiri,et al.  Matrix density-induced mechanoregulation of breast cell phenotype, signaling, and gene expression through a FAK-ERK linkage , 2009, Oncogene.

[29]  Christine Unger,et al.  In vitro cell migration and invasion assays. , 2013, Mutation research.

[30]  D. Elder,et al.  A tumorigenic subpopulation with stem cell properties in melanomas. , 2005, Cancer research.

[31]  J. Castle,et al.  Exploiting the mutanome for tumor vaccination. , 2012, Cancer research.

[32]  K. Hunter,et al.  Modeling metastasis in vivo. , 2004, Carcinogenesis.

[33]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[34]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[35]  R. DePinho,et al.  BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.

[36]  Mark Shackleton,et al.  Efficient tumour formation by single human melanoma cells , 2008 .

[37]  I. Gimenez-Conti,et al.  Genetic Analysis of Neoplasia Induced by N-Nitroso-N-methylurea in Xiphophorus Hybrid Fish , 2001, Marine Biotechnology.

[38]  N. Haass,et al.  Melanoma's connections to the tumour microenvironment. , 2013, Pathology.

[39]  Z. Werb,et al.  Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.

[40]  Z. Abdel‐Malek,et al.  Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. , 2011, Molecular endocrinology.

[41]  F. Bérard,et al.  The study of cutaneous melanomas in Camargue-type gray-skinned horses (1): clinical-pathological characterization. , 2000, Pigment cell research.

[42]  M. Herlyn,et al.  CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1 , 2006, The Journal of cell biology.

[43]  C. Busch,et al.  Noggin blocks invasive growth of murine B16‐F1 melanoma cells in the optic cup of the chick embryo , 2008, International journal of cancer.

[44]  C. Busch,et al.  The Chick Embryo as an Experimental System for Melanoma Cell Invasion , 2013, PloS one.

[45]  Eric Brown,et al.  Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. , 2005, The American journal of pathology.

[46]  Morag Park,et al.  Dynamics of receptor trafficking in tumorigenicity. , 2012, Trends in cell biology.

[47]  M. Herlyn,et al.  Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway , 2011, Oncogene.

[48]  R. DePinho,et al.  Ink4a/arf deficiency promotes ultraviolet radiation-induced melanomagenesis. , 2002, Cancer research.

[49]  C. Busch,et al.  Neural crest cell migration of mouse B16-F1 melanoma cells transplanted into the chick embryo is inhibited by the BMP-antagonist noggin. , 2007, International journal of oncology.

[50]  C. Busch,et al.  Non-malignant migration of B16 mouse melanoma cells in the neural crest and invasive growth in the eye cup of the chick embryo , 2007, Melanoma research.

[51]  D. Rimm,et al.  β-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. , 2011, Cancer cell.

[52]  W. Silvers,et al.  Transgenic mouse model of malignant skin melanoma. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[53]  C. Busch,et al.  Human SK-Mel 28 melanoma cells resume neural crest cell migration after transplantation into the chick embryo , 2005, Melanoma research.

[54]  M. Schartl,et al.  A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies. , 2010, The Journal of investigative dermatology.

[55]  Mohamed H. Sayegh,et al.  Identification of cells initiating human melanomas , 2008, Nature.

[56]  Baocun Sun,et al.  The in-vitro spheroid culture induces a more highly differentiated but tumorigenic population from melanoma cell lines , 2013, Melanoma research.

[57]  M. Herlyn,et al.  In vitro three-dimensional tumor microenvironment models for anticancer drug discovery , 2008, Expert opinion on drug discovery.

[58]  Shelly R. Peyton,et al.  A novel three-dimensional model to quantify metastatic melanoma invasion , 2007, Molecular Cancer Therapeutics.

[59]  J. Spitsbergen Imaging neoplasia in zebrafish , 2007, Nature Methods.

[60]  S. Holmen,et al.  Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma , 2011, Chinese journal of cancer.

[61]  M. Herlyn,et al.  Fibroblast‐dependent differentiation of human microvascular endothelial cells into capillary‐like, three‐dimensional networks , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[62]  L. Chin,et al.  Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.

[63]  D. Elder,et al.  Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. , 1993, The American journal of pathology.

[64]  L. Chin,et al.  Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. , 1997, Genes & development.

[65]  Keith T Flaherty,et al.  Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases , 2006, Molecular Cancer Therapeutics.

[66]  C. Garbe,et al.  Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment , 2007, The British journal of dermatology.

[67]  D. Iliopoulos,et al.  In vitro properties of human melanoma cells metastatic in nude mice. , 1990, Cancer research.

[68]  D. Mitchell,et al.  Genetic and environmental melanoma models in fish , 2010, Pigment cell & melanoma research.

[69]  A. P. Butler,et al.  Genetic Analysis of Susceptibility to Spontaneous and UV-Induced Carcinogenesis in Xiphophorus Hybrid Fish , 2001, Marine Biotechnology.

[70]  Wolfgang Link,et al.  Protein localization in disease and therapy , 2011, Journal of Cell Science.

[71]  R. Walter,et al.  Xiphophorus interspecies hybrids as genetic models of induced neoplasia. , 2001, ILAR journal.

[72]  C. Busch,et al.  Melanoma cells in distinct growth phases retain specific invasive qualities during brain metastasis in vivo , 2012, Pigment cell & melanoma research.

[73]  L. Chin,et al.  Animal models of melanoma: recent advances and future prospects. , 2000, Advances in cancer research.

[74]  R R Hook,et al.  Melanoma in Sinclair swine: a new animal model. , 1974, The Journal of investigative dermatology.

[75]  P. Hersey,et al.  The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance. , 2013, Carcinogenesis.

[76]  J. Reis-Filho,et al.  Oncogenic Braf induces melanocyte senescence and melanoma in mice. , 2009, Cancer cell.

[77]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[78]  F. Bérard,et al.  The study of cutaneous melanomas in Camargue-type gray-skinned horses (2): epidemiological survey. , 2000, Pigment cell research.

[79]  R. Jain Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[80]  P. Hersey,et al.  Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737 , 2011, Clinical Cancer Research.

[81]  Leonard I. Zon,et al.  Cancer genetics and drug discovery in the zebrafish , 2003, Nature Reviews Cancer.

[82]  M. Amoss,et al.  Regression by differentiation in the Sinclair swine model of cutaneous melanoma , 1997, Melanoma research.

[83]  D. Elder,et al.  Human melanoma progression in skin reconstructs : biological significance of bFGF. , 2000, The American journal of pathology.

[84]  C. Berking,et al.  Human skin reconstruct models: a new application for studies of melanocyte and melanoma biology. , 2001, Histology and histopathology.

[85]  L. Zon,et al.  BRAF Mutations Are Sufficient to Promote Nevi Formation and Cooperate with p53 in the Genesis of Melanoma , 2005, Current Biology.